• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of disodium cromoglycate (Intal) on sputum protein composition.色甘酸钠(咽泰)对痰液蛋白质成分的影响。
Thorax. 1972 Nov;27(6):726-8. doi: 10.1136/thx.27.6.726.
2
A double-blind trial of disodium cromoglycate (Intal) in the treatment of bronchial asthma.色甘酸钠(因他利)治疗支气管哮喘的双盲试验。
Can Med Assoc J. 1971 Oct 23;105(8):827-31.
3
[Treatment of asthma with Intal (disodium cromoglycate)].
Pol Arch Med Wewn. 1974 Jun;52(1):79-83.
4
[Disodium cromoglycate (Intal) in the treatment of bronchial asthma].
Lijec Vjesn. 1973 Jun;95(6):330-5.
5
Treatment of bronchial asthma with disodium cromoglycate (Intal) in children.色甘酸钠(咽泰)治疗儿童支气管哮喘
Ann Allergy. 1971 Dec;29(12):613-20.
6
[Treatment of bronchial asthma by disodium cromoglycate (Intal)].
Vojnosanit Pregl. 1975 May-Jun;32(3):297-9.
7
[Effect of disodium cromoglycate (Intal) on the course of endogenous steroid-dependent bronchial asthma].
Pneumonol Pol. 1981;49(4):291-4.
8
[Results in the treatment of allergic asthma using disodium cromoglycate (Intal)].[色甘酸钠(因他利)治疗过敏性哮喘的结果]
Med Welt. 1974 Feb 15;25(7):278-80.
9
[Disodium cromoglycate (Intal) in bronchial asthma].[色甘酸钠(因他美)在支气管哮喘中的应用]
Ther Ggw. 1981 Mar;120(3):265-77.
10
[Treatment of bronchial asthma with disodium cromoglycate (Intal)].
Med Interna (Bucur). 1971 Jun;23(6):721-8.

引用本文的文献

1
Stabilization of Tuberculosis Reporter Enzyme Fluorescence (REFtb) Diagnostic Reagents for Use at the Point of Care.用于即时检测的结核报告酶荧光(REFtb)诊断试剂的稳定性
Diagnostics (Basel). 2022 Jul 19;12(7):1745. doi: 10.3390/diagnostics12071745.
2
Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.色甘酸钠:其作用机制、药理学、治疗效果及应用综述
Drugs. 1974;7(3):164-282. doi: 10.2165/00003495-197407030-00002.
3
Antiasthmatic drugs I: pathophysiological and clinical pharmacological aspects.抗哮喘药物I:病理生理学和临床药理学方面
Drugs. 1974;7(5):344-69. doi: 10.2165/00003495-197407050-00005.
4
Plasma exudation and asthma.血浆渗出与哮喘。
Lung. 1988;166(1):1-23. doi: 10.1007/BF02714025.
5
The coughing that gets them down.令他们痛苦的咳嗽。
Br Med J. 1977 May 28;1(6073):1374-5.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.圆盘电泳。II. 方法及其在人血清蛋白中的应用。
Ann N Y Acad Sci. 1964 Dec 28;121:404-27. doi: 10.1111/j.1749-6632.1964.tb14213.x.
3
SERUM PROTEINS IN SPUTUM OF PATIENTS WITH ASTHMA.哮喘患者痰液中的血清蛋白
J Allergy. 1964 Sep-Oct;35:464-71. doi: 10.1016/0021-8707(64)90072-3.
4
Steroid-sparing effect of disodium cromoglycate ("Intal") in chronic asthma.
Med J Aust. 1969 Mar 15;1(11):566-9. doi: 10.5694/j.1326-5377.1969.tb92293.x.
5
Variation in the composition of sputum in chronic chest diseases.慢性胸部疾病中痰液成分的变化。
Br J Exp Pathol. 1968 Dec;49(6):625-33.
6
Prospects in asthma therapy: disodium cromoglycate and diethylcarbamazine.哮喘治疗的前景:色甘酸钠和乙胺嗪。
N Engl J Med. 1968 Nov 7;279(19):1055-7. doi: 10.1056/NEJM196811072791912.
7
Effect of disodium cromoglycate on exercise-induced asthma.色甘酸钠对运动诱发性哮喘的作用。
Br Med J. 1968 Sep 7;3(5618):593-4. doi: 10.1136/bmj.3.5618.593.
8
Relation between sputum sol phase composition and diagnosis in chronic chest diseases.慢性胸部疾病中痰液溶胶相成分与诊断的关系。
Thorax. 1971 Jul;26(4):418-23. doi: 10.1136/thx.26.4.418.
9
The mucolytic agent bromhexine (bisolvon) in chronic lung disease. A double-blind crossover trial.慢性肺病中黏液溶解剂溴己新(必嗽平):一项双盲交叉试验
Aust N Z J Med. 1971 May;1(2):137-40. doi: 10.1111/j.1445-5994.1971.tb02280.x.
10
Protein concentrations in sputa from asthmatic children. Albumin, lactoferrin, gamma A and gamma G.哮喘儿童痰液中的蛋白质浓度。白蛋白、乳铁蛋白、γA和γG。
J Lab Clin Med. 1969 May;73(5):734-43.

色甘酸钠(咽泰)对痰液蛋白质成分的影响。

Effect of disodium cromoglycate (Intal) on sputum protein composition.

作者信息

Heilpern S, Rebuck A S

出版信息

Thorax. 1972 Nov;27(6):726-8. doi: 10.1136/thx.27.6.726.

DOI:10.1136/thx.27.6.726
PMID:4630567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC469971/
Abstract

The protein content in the sputum of nine patients with asthma was compared with that in 11 non-asthmatic patients by a method of gel electrophoresis. It was found that the albumin content was significantly higher in the sputum of the asthmatics than of the non-asthmatics (P<0·01). A further 11 asthmatic patients who were taking disodium cromoglycate (Intal) as part of their treatment had sputum albumin levels indistinguishable from the non-asthmatics. When patients with asthma were then studied serially, before and after disodium cromoglycate therapy, the albumin content returned to non-asthmatic levels within two days of starting treatment. It is suggested that disodium cromoglycate has a previously unrecognized action in altering sputum proteins.

摘要

采用凝胶电泳法对9例哮喘患者痰液中的蛋白质含量与11例非哮喘患者痰液中的蛋白质含量进行了比较。结果发现,哮喘患者痰液中的白蛋白含量显著高于非哮喘患者(P<0·01)。另有11例正在接受色甘酸钠(咽泰)治疗的哮喘患者,其痰液白蛋白水平与非哮喘患者无异。随后对哮喘患者在色甘酸钠治疗前后进行了连续研究,发现治疗开始后两天内白蛋白含量恢复到非哮喘患者的水平。提示色甘酸钠在改变痰液蛋白质方面具有此前未被认识到的作用。